Tideglusib for amyotrophic lateral sclerosis
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether an experimental drug called tideglusib can slow the progression of ALS. It is for people with a recent ALS diagnosis whose breathing is still fairly strong.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS (possible, probable, or definite).
- Your symptoms started less than 18 months ago.
- Your breathing strength (vital capacity) is more than 60% of normal.
- You are 18 or older.
- You are on a stable dose of riluzole or edaravone, or not taking them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called tazbentetol for people with ALS (amyotrophic lateral sclerosis), a disease that affects nerve cells controlling muscles. The goal is to see if it is safe and effective, and it may help slow the progression of the disease.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests whether a medicine called cyclophosphamide can slow the progression of ALS. It's given to people who have had symptoms for less than 2 years and still have good breathing, to see if calming the immune system can help protect nerve cells.
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
This trial tests a new drug, RAG-17, for people with ALS who have a specific SOD1 gene mutation. The goal is to see if it's safe and how it affects the body, which may help slow the disease.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.